ACH vs LEN · rev $10.70B vs rev $34.19B
Accendra Health Inc (ACH) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
LEN (LEN) common stock.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
ACH currently screens at market cap $237.8M. LEN currently screens at market cap $0.
Not investment advice. Open the ACH and LEN stock pages for the full models.
Not investment advice.